Today on Pharmaceutical Processing
Biogen is scaling back space outside Boston
According to reports, Biogen has taken steps to scale back costs following the release of its Aduhelm Alzheimer’s disease drug. The company has moved to sublease more than 260,000 square feet at multiple locations in Massachusetts as it looks to cut $1 billion in costs, The Boston Globe reported. Across from its Cambridge, Massachusetts, headquarters, the…
Fresenius Kabi plans to add 2D barcodes to its pharmaceutical portfolio
Fresenius Kabi has announced a three-year plan to add GS1 Data Matrix barcodes to its pharmaceutical portfolio. GS1 Data Matrix barcodes are also known as 2D barcodes. The company manufactures a range of vials, syringes, IV products and parenteral nutrition products. The Lake Zurich, Illinois–based company says the decision will reduce the need for manual data entry…
Sponsored Content See More >
A new way to access scientific papers?Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA AssaysBy Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing…
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
Ultra Supplement announces recall for undeclared tadalafil
The FDA continues to pressure manufacturers and distributors for selling products with undeclared sildenafil and tadalafil. The agency recently announced that Wilmington Delaware–based Ultra Supplement LLC is voluntarily recalling lot number DAP272109 of Sustango capsules over the presence of tadalafil (Cialis). The company markets the product as a supplement for men. Sustango was available for…
Facility See More >
Astellas to spend $70M on new biotech campus in South San Francisco
Astellas Pharma (TSE: 4503) plans to establish a biotech campus in South San Francisco, California, as the core of its West Coast R&D operations. Located near Genentech and Verily Life Sciences facilities, the site at 480 Forbes Boulevard will consolidate several Astellas business units and functions currently based throughout the San Francisco Bay Area. The…
Supply Chain See More >
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina. San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight. The flights starting today…
Recalls See More >
Taro Pharmaceuticals announces Type I recall of Taro-zoledronic acid injection
The Canadian division of Taro Pharmaceuticals (NYSE:TARO) has announced a voluntary Type 1 recall on six lots of Taro-zoledronic Acid Injection. Type 1 recalls, according to Health Canada, refer to products that could cause serious adverse health consequences or death. It corresponds to Class 1 recalls from the FDA. Taro Pharmaceutical‘s consumer-level recall covers 5 mg/100…